W H Miller|M C Hyatt - JoVE Visualize

Showing results (151-160 of 230) with videos related to

Pageof 23

Sort By:

Cancer Research|December 15, 1994

9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and proteinM Rubin, E Fenig, A Rosenauer, et al.

Blood|January 25, 1992

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1987

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptaseM H St Clair, C A Richards, T Spector, et al.

Cell|September 2, 1991

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PMLA Kakizuka, W H Miller, K Umesono, et al.

The Journal of Clinical Investigation|May 20, 1999

CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatmentD J Park, A M Chumakov, P T Vuong, et al.

The Journal of Thoracic and Cardiovascular Surgery|January 1, 1980

Percutaneous transluminal angioplasty in the management of occlusive disease involving the coronary arteries and saphenous vein bypass grafts: preliminary resultsW B Ford, M H Wholey, E A Zikria, et al.

British Journal of Cancer|October 6, 2011

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence scoreS Sahebjam, R Aloyz, D Pilavdzic, et al.

Oncogene|December 1, 1993

Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cellJ Baselga, W J Maerz, D Moy, et al.

Differentiation; Research in Biological Diversity|January 1, 1994

All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomasW H Miller, W J Maerz, J Kurie, et al.

The Journal of Thoracic and Cardiovascular Surgery|November 11, 1992

Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancerV W Rusch, V E Reuter, M G Kris, et al.

Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:

Pageof 23

Cancer Research|December 15, 1994

9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and proteinM Rubin, E Fenig, A Rosenauer, et al.

Blood|January 25, 1992

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.

Antimicrobial Agents and Chemotherapy|December 1, 1987

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptaseM H St Clair, C A Richards, T Spector, et al.

Cell|September 2, 1991

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PMLA Kakizuka, W H Miller, K Umesono, et al.

The Journal of Clinical Investigation|May 20, 1999

CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatmentD J Park, A M Chumakov, P T Vuong, et al.

The Journal of Thoracic and Cardiovascular Surgery|January 1, 1980

Percutaneous transluminal angioplasty in the management of occlusive disease involving the coronary arteries and saphenous vein bypass grafts: preliminary resultsW B Ford, M H Wholey, E A Zikria, et al.

British Journal of Cancer|October 6, 2011

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence scoreS Sahebjam, R Aloyz, D Pilavdzic, et al.

Oncogene|December 1, 1993

Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cellJ Baselga, W J Maerz, D Moy, et al.

Differentiation; Research in Biological Diversity|January 1, 1994

All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomasW H Miller, W J Maerz, J Kurie, et al.

The Journal of Thoracic and Cardiovascular Surgery|November 11, 1992

Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancerV W Rusch, V E Reuter, M G Kris, et al.

Pageof 23